Celldex Therapeutics Inc (CLDX)
EBITDA Margin
-265353.57%
TTM · Period ending:
CLDX EBITDA Margin
Latest reported-265353.57%period ending
Latest reported-265353.57%period ending
CLDX TTM EBITDA Margin (145.45% → -265353.57%)
TTM ebitda margin
High-resolution chart · PNG
CLDX ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -868.9857% | |
| -1,069.2454% | |
| -1,851.4151% | |
| -2,910.2898% | |
| -1,864.9526% | |
| -769.3412% | |
| -681.3482% | |
| -321.2346% | |
| -309.337% | |
| -376.1905% | |
| -313.6364% | |
| -440% | |
| -541.6667% | |
| -425% | |
| -561.5385% | |
| -691.6667% | |
| -700% | |
| -1,557.1429% | |
| -925% | |
| -633.3333% | |
| -500% | |
| -305.7143% | |
| -270.7317% | |
| -242.8571% | |
| -189.7959% | |
| -155.9322% | |
| -125.7143% | |
| -108.5366% | |
| -105.6818% | |
| -93.4783% | |
| -93.4066% | |
| -76.5306% | |
| -61.3861% | |
| -62.6263% | |
| -40.8333% | |
| -52.7778% | |
| -58.4158% | |
| -51.9608% | |
| -64.7059% | |
| -46.8085% | |
| -38.2353% | |
| -23.4234% | |
| -15% | |
| 11.8644% | |
| 40.3509% | |
| -26.2136% | |
| -8.046% | |
| -14.6341% | |
| -20.5128% | |
| -4.7619% | |
| -11.8644% | |
| -26.9231% | |
| -46.6667% | |
| 2.5641% | |
| -18.75% | |
| -46.1538% | |
| -111.1111% | |
| -400% | |
| 183.3333% | |
| 145.4545% |